Sébastien Morin
LightNews LightNews
banner
sebmoringva.bsky.social
Sébastien Morin
@sebmoringva.bsky.social
58 followers 120 following 45 posts
Senior Manager - Policy, Strategy and Market Access
Medicines Patent Pool (Switzerland)
[ Posting on #GlobalHealth in personal capacity. ]
⭐️ Health is a human right ⭐️
Posts Replies Media Videos
Reposted by Sébastien Morin
medicinespatentpool.org
🎥 New MedsPaL Video Series!

Continuing our mission to help users navigate the enhanced #MedsPaL platform! 🌍💊

🔍 You’ll learn how to explore #licence data efficiently and unlock valuable insights for your work!

🔗 Explore more at: www.medspal.org
January 15, 2026 at 11:34 AM
Reposted by Sébastien Morin
medicinespatentpool.org
Yesterday, the #AORTIC Medical Oncology Special Interest Group held a panel on Expanding #Immunotherapy #Access in Africa: Early Lessons and Cost Considerations 🌍

The discussion offered lessons for expanding equitable access to life-saving #treatments across the continent ✨
January 16, 2026 at 2:22 PM
Reposted by Sébastien Morin
medicinespatentpool.org
🌍 MPP is hiring!

In partnership with Ganci Partners, MPP is seeking an #ExecutiveDirector to lead our mission of delivering life-saving medicines to those who need them most.

📧 Apply by Feb 16, 2026
👉 lnkd.in/eyMVr_vj
January 16, 2026 at 5:04 PM
sebmoringva.bsky.social
Working tirelessly behind every licence & would-be licences !

See our in-licensing #priorities: #HIV; #HCV; #HBV; #TB; #infant #RSV #prevention; #malaria; #PPR; #CF; #cancer; #diabetes; #cardiovascular; #metabolics

lnkd.in/eSFfWKbR ! ⭐

#Equity #AccessToMedicines
#BetterMeds4Kids #GlobalHealth
December 10, 2025 at 4:04 PM
Reposted by Sébastien Morin
medicinespatentpool.org
#RSV causes 100,000 child deaths yearly — almost entirely in LMICs. On #WPD, MPP calls for urgent action to make prevention tools like #nirsevimab and #clesrovimab widely accessible, esp. in LMICs.

Voluntary licensing can help close the gap. Learn more: medicinespatentpool.org/story-post/p...
November 13, 2025 at 8:18 AM
Reposted by Sébastien Morin
medicinespatentpool.org
On #WorldDiabetesDay, we stand with @who.int’s call: #diabetes affects every life stage. Two inspiring women share their journeys through #pregnancy with #Type1diabetes— highlighting urgent needs for affordable #insulin, tech access, and #education. No one should be left behind.

🔗 bit.ly/3WYVNzB
November 14, 2025 at 3:14 PM
Reposted by Sébastien Morin
medicinespatentpool.org
🦠 #RSV kills 100,000+ young children yearly, 97% in LMICs. Prevention works, but access to life-saving monoclonal antibodies is limited. On #WorldChildrensDay, let’s push for affordable RSV prevention so every child gets a healthy start. Learn more: bit.ly/4o0XGqo
Preventing a hidden killer of infants in low- and middle-income countries - MPP
Respiratory syncytial virus (RSV) is the leading causes of lower respiratory tract infections and mortality among young children across the world. Estimates suggest it causes over 100,000 deaths and 3...
bit.ly
November 20, 2025 at 8:41 AM
Reposted by Sébastien Morin
medicinespatentpool.org
MPP provides sustainable solutions that save millions of lives in the short and long run. 🌍 MPP punches well above its weight. 💪

Would you like to explore ways in which we could collaborate? 🤝

Get in touch: medicinespatentpool.org/licensingsav...

#Sustainability #FundingHealthEquity
November 21, 2025 at 8:58 AM
Reposted by Sébastien Morin
medicinespatentpool.org
MPP’s work in #licensing, #techtransfer and capacity-building aligns with Article 12’s benefit-sharing goals. We’ve long partnered with @who.int and Member States to turn these principles into access. 🤝🌍

👉 medicinespatentpool.org/news-publica...
MPP's Statement at the WHO Intergovernmental Working Group - MPP
Question: “How could your entity contribute in a practical and sustainable manner to the Pathogen Access and Benefit Sharing System (PABS)?” Statement  We believe that Medicines Patent Pool (MPP) can ...
medicinespatentpool.org
November 24, 2025 at 2:43 PM
Reposted by Sébastien Morin
medicinespatentpool.org
🌍 Around the world, millions of people cannot access the medicines they need — not because the treatments don’t exist, but because they remain out of reach.

At MPP, we work to change that.

✨ Join us: lnkd.in/eDizXjQb

Watch the video: www.youtube.com/watch?v=3kqd...

#LicensingSavesLives
#LicensingSavesLives - Pushing the boundaries of global health access
YouTube video by MedicinesPatentPool
www.youtube.com
November 27, 2025 at 2:26 PM
Reposted by Sébastien Morin
medicinespatentpool.org
MPP joins @who.int @unaids.org @unitaid.bsky.social & partners to mark #WorldAIDSDay. Expanding access to dolutegravir-based regimens, paediatric formulations & long-acting therapeutics is vital for equity & choice. Through licensing, MPP helps make this possible.
🔗 shorturl.at/gEMKd
#LicensingSavesLives - Pushing the boundaries of global health access
YouTube video by MedicinesPatentPool
youtu.be
December 1, 2025 at 12:02 PM
Reposted by Sébastien Morin
medicinespatentpool.org
MPP and @unitaid.bsky.social are co-hosting “Breaking New Grounds: Long-Acting HIV Treatment for a New Generation”, at #ICASA2025.

📅 Wednesday 3 December 2025 | 11:45–12:30 GMT
📍 Room Prof. Souleymane Mboup & online

Join us to discuss why long-acting HIV treatment matters.
lnkd.in/e7DTMEYc
December 2, 2025 at 12:18 PM
Reposted by Sébastien Morin
medicinespatentpool.org
Yesterday, @who.int released its first-ever guideline on the use of GLP-1 therapies for adults living with obesity. This milestone follows the inclusion of GLP-1 medicines in the Essential Medicines List for managing type 2 diabetes in high-risk groups.

👉 www.who.int/news/item/01...
WHO issues global guideline on the use of GLP-1 medicines in treating obesity
To address the growing global health challenge of obesity, which affects more than 1 billion people, WHO has released its first guideline on the use of Glucagon-Like Peptide-1 (GLP-1) therapies for tr...
www.who.int
December 2, 2025 at 5:10 PM
sebmoringva.bsky.social
On #WorldAIDSDay, let's remember the role of #communities in driving the response, and how #access to optimal #HIV care - for everyone living with HIV - supports #solidarity and #dignity in the broader journey towards #progress 🤍
medicinespatentpool.org Medicines Patent Pool @medicinespatentpool.org · Nov 30
💊 Every pack of #HIV treatment delivered through MPP licences means a life transformed. Ahead of #WorldAIDSDay, meet Hue from #Vietnam, mother, advocate & fighter. W/ improved treatment & community support, she turned stigma into strength and now helps others do the same.
🔗 bit.ly/43Vpbe6
World AIDS Day — A Life of Strength and Hope — Tran Thi Hue - MPP
At the Medicines Patent Pool (MPP), our mission is simple yet vital — to ensure that the best medicines reach the people who need them most. Every licence we negotiate, every partnership we forge, and...
medicinespatentpool.org
December 1, 2025 at 11:25 AM
sebmoringva.bsky.social
On #WorldAIDSDay, let's remember how #access to optimal #HIV care - for everyone living with HIV - supports #solidarity and #dignity in the broader journey towards #progress 🤍
December 1, 2025 at 11:21 AM
Reposted by Sébastien Morin
medicinespatentpool.org
On #WorldChildrensDay, MPP proudly stands as a founding member of GAP-f, driving global collaboration to ensure children everywhere have access to lifesaving medicines.

Learn more: www.who.int/initiatives/...

@pablorojo.bsky.social @sebmoringva.bsky.social
November 20, 2025 at 1:20 PM
sebmoringva.bsky.social
It was a pleasure to take part in GAP-f annual members' meeting, reviewing the tremendous #progress of our collaborative network in prioritizing #BetterMeds4Kids in 5 new therapeutic areas during 2025! -> This is what #WorldChildrensDay is about!

#SickleCellDisease #Epilepsy #RSV #Dengue #Malaria
November 20, 2025 at 5:22 PM
sebmoringva.bsky.social
Today is #WorldChildrensDay - It is a time to reflect and ask ourselves if we have continued to #prioritize #children this last year. While we never exclude children outright, we often forget to #adapt our #efforts to their #needs. Let's changed that & develop #BetterMeds4Kids! 🤍
A man hold his child in his arms.
November 20, 2025 at 8:22 AM
sebmoringva.bsky.social
Among 100,000 #RSV deaths/year in children, 97% are in #LMICs & half in infants <6 months. Today is #WorldChildrensDay & we are reminded about inequitable diseases disproportionately affecting our young loved ones. Let's work together & create real change! 🤍
#Equity #GlobalHealth #BetterMeds4Kids
November 20, 2025 at 8:05 AM
sebmoringva.bsky.social
This #FixedDoseCombination (combining 3 drugs in 1 tablet: #pALD) allows children to benefit from #innovation as adults have enjoyed for many years. This #equity supports #adherence and better #health outcomes for our loved young ones. 🤍
-
#BetterMeds4Kids #WorldChildrensDay #ChildrenLivingWithHIV
medicinespatentpool.org Medicines Patent Pool @medicinespatentpool.org · Nov 18
As countries are transitioning to the best first-line regimen for #children living with #HIV, we are happy to share that for the first time in Q1 and Q2 of 2025, orders for paediatric ALD have surpassed the orders of paediatric DTG regimen. 👶

Together, we continue to advance paediatric HIV care! 🤝
November 18, 2025 at 1:48 PM
Reposted by Sébastien Morin
medicinespatentpool.org
As countries are transitioning to the best first-line regimen for #children living with #HIV, we are happy to share that for the first time in Q1 and Q2 of 2025, orders for paediatric ALD have surpassed the orders of paediatric DTG regimen. 👶

Together, we continue to advance paediatric HIV care! 🤝
November 18, 2025 at 9:15 AM
Reposted by Sébastien Morin
medicinespatentpool.org
Continued and diversified funding is essential for MPP to expand its mandate and future projects. Your contribution can make a significant impact.

Would you like to explore ways in which we could collaborate?
👉 medicinespatentpool.org/licensingsav...

#FundingHealthEquity #GlobalHealth
November 10, 2025 at 4:24 PM
Reposted by Sébastien Morin
medicinespatentpool.org
With 🇹🇳 #AORTIC2025 now wrapped up, we want to thank everyone who joined our #MythBuster game at the Medicines Patent Pool booth!

#Oncology professionals, researchers, policymakers, and advocates shared powerful insights about the realities of #cancercare in LMICs.

#AccessToMedicines #HealthEquity
November 7, 2025 at 4:42 PM
sebmoringva.bsky.social
The Global Accelerator for Paediatric Formulations (GAP-f) at
@who.int & @accesstomedicinefoundation.org invite pharmaceutical innovators & manufacturers to discuss the GAP-f 2025-30 strategy & discuss medicines for childhood cancer, epilepsy, malaria, RSV -> Register at who.zoom.us/meeting/regi...
Welcome! You are invited to join a meeting: GAP-f Private Sector Entities Dialogue 2025. After registering, you will receive a confirmation email about joining the meeting.
Welcome! You are invited to join a meeting: GAP-f Private Sector Entities Dialogue 2025. After registering, you will receive a confirmation email about joining the meeting.
who.zoom.us
October 22, 2025 at 3:11 PM
Reposted by Sébastien Morin
medicinespatentpool.org
Around 375 patients with #chronicmyeloidleukaemia (CML) in El Salvador, Indonesia & the Philippines are now accessing quality-assured generic #nilotinib.

Made possible through a #voluntarylicence from @novartis.bsky.social to MPP via the ATOM coalition - @uiccofficial.bsky.social!

lnkd.in/eruiP-Gv
September 22, 2025 at 1:52 PM